India Sets Out Modalities Of Perpetual Licensing Initiative
Executive Summary
India has outlined key aspects of its recently introduced perpetual licensing system, including initial modalities around joint inspections of manufacturing units by central and state drug inspectors.
You may also be interested in...
India’s Risk-Based Inspection Plan: Well Begun?
India's CDSCO is taking definitive steps to strengthen the regulatory regime and enforcement, including across areas such as data integrity, against the backdrop of industry's patchy manufacturing compliance.
India IPR Realities: Pharma, Legal Heads Discuss Winds Of Change, ‘Damocles Sword’
Leaders from Novartis, Bayer, Sun Pharma, the Indian Pharmaceutical Alliance, Médecins Sans Frontières and Anand and Anand discuss India’s evolving intellectual property rights landscape, including pre-grant oppositions, enforcement action and other realities. Concerns around evergreening, restrictions on patent-eligible subject matter and compulsory licensing were also key talking points at a recent conference in Hyderabad.
India IPR Wheels Are Turning: Novartis, Bayer, Sun, Legal Heads Discuss Realities
Leaders from Novartis, Bayer, Sun Pharma, the Indian Pharmaceutical Alliance, Médecins Sans Frontières and Anand and Anand discuss India’s evolving intellectual property rights landscape, including pre-grant oppositions, enforcement action and other realities. Concerns around evergreening, restrictions on patent-eligible subject matter and compulsory licensing were also key talking points at a recent conference in Hyderabad.